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ABSTRACT
Fatigue affects between 42% and 89% of end-stage kidney disease (ESKD)
patients, with significant repercussions on quality of life and clinical
outcomes. Fatigue management revolves around pharmacotherapy or
exercise, which have only modest and short-term improvements. The
aim of this systematic review was to investigate whether social-
psychological interventions are effective at reducing fatigue in ESKD.
Databases were searched to identify randomized controlled trials (RCTs)
and quasi-RCTs that determined the effect of social-psychological
interventions on fatigue (primary or secondary outcome), in the renal
patient population. A meta-analysis was conducted. Sixteen RCTs (N =
1536) were included, predominantly among dialysis patients. Fatigue
was a primary outcome in only two studies. The meta-analytic findings
showed a significant improvement in fatigue following social-
psychological interventions (standardised mean difference, SMD = 0.37,
p = .001; 95% CI 0.15 to 0.59, I² = 69.1%, p < .001). There was evidence
for greater effectiveness of interventions including stress-management/
relaxation techniques, evaluated among fatigued samples meeting
diagnostic thresholds, against passive/non-active comparison groups.
The studies were generally of poor quality, with high heterogeneity,
particularly with the number of sessions ranging from 2 to 96.
Development and evaluation of a fatigue-specific social-psychological
intervention is warranted in this setting.
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Chronic kidney disease (CKD) involves progressive renal damage and loss in renal functioning
(Haynes & Winearls, 2010), leading to hypertension, an accumulation of calcium and phosphate,
and impaired erythropoietin production (Haynes & Winearls, 2010; Levey et al., 2003; Levey et al.,
2005; Levin et al., 2008). An estimated 8–16% worldwide suffer from CKD (Jha et al., 2013), with a
6–8% growth per annum of dialysis patients, classifying it as a worldwide epidemic (Levin, 2003).
CKD management is complex, relying on treating the underlying causes, such as hypertension or dia-
betes, slowing down the progression of renal damage, treating CKD-related complications, like
anaemia (Haynes & Winearls, 2010), and substituting the role of kidneys via renal replacement
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therapy (RRT) in end-stage kidney disease (ESKD) (Haynes & Winearls, 2010; Levin et al., 2008). Renal
insufficiency leads to a number of debilitating symptoms; fatigue, pruritus, sleep disturbance, pain,
and dry skin were found to be the most prominent symptoms in advanced CKD (Almutary,
Bonner, & Douglas, 2013; Murtagh et al., 2007).
Fatigue, a complex and subjective experience that has been described as ‘extreme and persistent
tiredness, weakness or exhaustion-mental, physical, or both’ (Artom, Moss-Morris, Caskey, & Chilcot,
2014; David et al., 1990; Pawlikowska et al., 1994), has consistently emerged as a major affliction for
CKD patients (Afshar, Rebollo-Mesa, Murphy, Murtagh, & Mamode, 2012; Caplin, Kumar, & Davenport,
2011; Curtin, Bultman, Thomas-Hawkins, Walters, & Schatell, 2002). It affects between 42% and 89% of
ESKD patients, depending on treatment modality and fatigue measurement used (Artom et al., 2014;
Bossola, Vulpio, & Tazza, 2011). There is extensive evidence that fatiguemay lead to reduced function-
ing and poorer clinical outcomes (Artom et al., 2014; Bonner, Caltabiano, & Berlund, 2013; Bossola et al.,
2015; Davison & Jhangri, 2010; Jhamb et al., 2009; Jhamb et al., 2011; Koyama et al., 2010); yet, it is often
under-recognised and under-treated by healthcare professionals, and often normalised as part of the
illness and treatment burden (Lee, Lin, Chaboyer, Chiang, & Hung, 2007;Weisbord et al., 2007). Fatigue-
specific treatments are currently scarce, and the vast majority of existing treatments revolve around
medications, such as L-carnitine, correction of anaemia, or involving patients in exercise. A review
of pharmacological treatments for fatigue in CKD reached the conclusion that none of the drugs
can be recommended for the prevention of fatigue, and complete and prolonged relief from
fatigue is rare (Bossola et al., 2011). Whilst correction of anaemia has consistently shown great
dose–response improvements in outcomes and quality of life, it is closely managed in renal patients,
with Hb levels maintained between 10 and 12 g/dL in adults (Revicki et al., 1995). Consequently, there
is a ceiling effect of anaemia management, and often fatigue persists when anaemia is controlled.
Exercise-based treatments are heterogeneous, varying in modality, delivery mode, frequency, dur-
ation, and intensity (Artom et al., 2014; Bossola et al., 2011). Multiple systematic reviews of exercise
interventions in this patient population are currently available (Cheema & Singh, 2005; Heiwe &
Jacobson, 2014; Segura-Ortí, 2010; Smart & Steele, 2011), and according to these, fatigue is rarely
the primary treatment target, and any improvements in fatigue are extrapolated from quality of
life outcomes. Therefore, exercise interventions may have some secondary benefits on the vitality
levels of renal patients (Chang, Cheng, Lin, Gau, & Chao, 2010; Painter, Carlson, Carey, Paul, & Myll,
2000; Storer, Casaburi, Sawelson, & Kopple, 2005; van Bergen et al., 2009; van Vilsteren, de Greef, &
Huisman, 2005). However, these exercise trials suffer from numerous methodological limitations
including, small sample sizes, inadequate reporting of participants, intervention, and outcome
characteristics, and low population validity, with the samples included in the majority of studies con-
sisting of younger patients undergoing haemodialysis (Cheema & Singh, 2005; Heiwe & Jacobson,
2014; Segura-Ortí, 2010; Smart & Steele, 2011). Furthermore, exercise interventions have been repeat-
edly criticised for being unsuitable for patients with multi-morbidities, disabilities, and in poorer
health (Kosmadakis et al., 2010). Whilst the effect of psychological interventions on fatigue in
other chronic conditions have been more extensively studied (Cramp et al., 2013; Jacobsen,
Donovan, Vadaparampil, & Small, 2007; Kangas, Bovbjerg, & Montgomery, 2008; Neill, Belan, &
Ried, 2006; van den Akker et al., 2016), the number of studies examining fatigue-specific psychothera-
pies in this patient population is currently limited (Artom et al., 2014).
Rationale
Given the debilitating nature of fatigue in ESKD, its management represents a clinical priority (Artom
et al., 2014). There is a need to systematically identify the currently available social-psychological
interventions that have benefits on fatigue in the renal population and assess the extent of
fatigue improvements across the different interventions. An estimate of the effectiveness in reducing
fatigue of different interventions can also inform a future more comprehensive and fatigue-focused
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intervention for renal patients. To the best of our knowledge, the efficacy of social-psychological
interventions for the management of fatigue in ESKD has not been systematically reviewed to date.
Objectives
The objectives of our review are:
(1) To assess the efficacy of current interventions at improving fatigue.
(2) To identify whether differences in efficacy exist depending on behaviour change techniques
(BCTs) used within the interventions.
Methods
Eligibility criteria
The inclusion/exclusion criteria can be found in Table 1. Only studies available in full-text were
included to ensure sufficient appraisal and review. No publication date/status or language restrictions
were imposed.
Table 1. PICOS inclusion/exclusion criteria.
Inclusion criteria Exclusion criteria
Study
design
RCTs or quasi-RCTs: Studies were included if the authors
used the word ‘random’ to describe the method for
assigning subjects to groups.
Uncontrolled intervention studies, or case series studies,
or observational studies.
Population Adults (minimum age 18 years). Children, adolescents (under 18 years).
Illness CKD of any aetiology and duration, stages 3–5 (eGFR
falling below 60 ml/minute/1.73m²).
Primary stages of kidney disease when eGFR still normal
or only slightly reduced (eGFR above 60 ml/minute/
1.73 m²).
Treatment Haemodialysis, at home or at a satellite unit; peritoneal
dialysis (automated or ambulatory); in pre-dialysis
care, Tx.
Conservatively managed patients.
Intervention A broad range of social-psychological interventions
were included, either targeting fatigue or including
fatigue/vitality as an outcome (primary or secondary).
We defined social-psychological interventions
according to criteria used in previous Cochrane
reviews of social-psychological interventions for other
long-term conditions (e.g., Goedendorp, Gielissen,
Verhagen, & Bleijenberg, 2009; Poort et al., 2016). This
definition included any intervention, involving
systematic treatment with some form of feedback or
review, including psychotherapy, psycho-education,
and interventions containing elements like: education,
goal-setting, cognitive restructuring, behavioural
strategies, relaxation training, stress management, or
support groups. Multimodal interventions, consisting
of both psychological and other therapeutic strategies
(e.g., exercise), were also included, if one or more
social-psychological therapeutic technique was clearly
evident. Both individual and group-focused
interventions were included, regardless of delivery
mode.
Excluding pharmacological interventions, exclusively
exercise interventions, interventions modifying the
dialysis schedule or parameters, alternative medicine
interventions (e.g., acupressure), interventions
revolving around making specific changes to the diet,
or psychological techniques aimed at improving
adherence to exercise interventions.
Control Any intervention versus placebo, no intervention (e.g.,
waiting-list control), or another active intervention
(including interventions given alone or in
combination).
N/A
Outcomes A validated self-report measure of fatigue including VAS
and the vitality subscale of the SF-36.
Excluding other outcomes, like physical functioning,
sleep quality, quality of life, mortality or distress and
muscle morphology outcomes, BMI, and objective
laboratory measurements of aerobic capacity.
Note: RCT: randomised controlled trial; eGFR: estimated glomerular filtration rate; CKD: chronic kidney disease; Tx: kidney transplant
recipient; VAS: visual analogue scale; BMI: body mass index.
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Information sources
Studies were identified by searching the following databases: PsycInfo on Ovid (1806–Present),
Medline on Ovid (1946–Present), Embase on Ovid (1974–Present), Global Health on Ovid (1973–
Present), Web of Knowledge (Core Collection, KCI-Korean Journal Database, SCIELO), Cumulative
Index to Nursing and Allied Health Literature (CINAHL) via EBSCOhost, and Cochrane Central Register
of Controlled Trials (CENTRAL). Grey literature was also searched, through the following databases: (1)
OpenGrey, (2) WorldCat, (3) British Library Electronic Theses Online Service (EThOS), and (4) DART-
Europe E-theses portal, without any hits. Additionally, references of the eligible articles were screened
to identify any relevant articles missed by the electronic and manual searches.
Search (December, 2015)
The search strategy included a combination of MeSH terms, and keywords with appropriate Boolean
operators (online Appendix A). The quality of the search strategy, tailored for each database, was eval-
uated by a librarian with expertise in database searches for reviews and the strategies were revised
accordingly. No limits were applied across the searches.
Study selection
The process of identifying studies for review consisted of four stages: identification, screening, eligi-
bility, and inclusion (Moher, Liberati, Tetzlaff, Altman, & Group, 2010). During the identification stage,
the chosen databases were searched and the citations were exported to EndNote X6. The citations
were screened for duplicates and the eligibility criteria both through the help of EndNote X6 and
a manual proof assessment that allowed the identification of papers reporting on the same
dataset. The full-texts of the remaining citations were retrieved and assessed according to the
inclusion/exclusion criteria, by two independent reviewers (FP and JLH) and any discrepancies
were resolved by discussion and consensus. Where consensus could not be reached, feedback of a
third author was sought. This process led to the final number of papers that were included in this
review.
Data collection and extraction process
Data from the included studies were extracted using a data extraction form which was adapted from
the data collection checklist by the Cochrane Effective Practice and Organisation of Care Review
Group (EPOC) to suit the purpose of this review. Key aspects of data extraction included: participant
characteristics, methods, fatigue outcome used, intervention description, data analyses, and results
for fatigue as an outcome. Where missing data were encountered, authors were contacted to retrieve
information. Descriptive data were presented using the Graphical Overview for Evidence Reviews
software (GOfER; Stahl-Timmins, 2014). The reliability of the coding and data extraction was assessed
by computing Kappa agreement between the two reviewers.
Outcome data
Recognised psychometric self-report measures of fatigue were extracted here, such as the Fatigue
Severity Scale (FSS; Krupp, LaRocca, Muir-Nash, & Steinberg, 1989) or the Vitality subscale of the
SF-36 (Ware Jr & Sherbourne, 1992; Ware, Snow, Kosinski, & Gandek, 1993).
To address Objective 2 and extrapolate BCTs of each intervention, the intervention descriptions
were coded by two reviewers against the behaviour change taxonomy BCTs taxonomy (Michie
et al., 2013) via the use of NVivo, a software developed for the analysis of qualitative data.
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Quality and risk of bias assessments
Within-study bias
Risk of bias (RoB) was assessed by two reviewers using the Cochrane Risk of Bias assessment tool. The
criteria used to assess RoB in this review included: random sequence generation, allocation conceal-
ment, blinding, incomplete outcome data, selective reporting, and the identification of any other
biases, such as inconsistent results, contamination between intervention and control groups, baseline
non-equivalence between groups, and the possibility of conflict of interest judged from the funding
information. Each study was classified into ‘low’, ‘high’, or ‘unclear’ RoB for each category. Disagree-
ments were solved by discussion and consensus, in cases where consensus could not be reached, the
opinion of a third reviewer was sought. Where information reported in the paper was insufficient or
unclear, authors were contacted. RoB ratings were presented using RevMan5 (Cochrane Collabor-
ation, 2014).
Additionally, all included studies underwent a quality assessment using a modified version of the
Effective Public Health Practice Project (EPHPP) quality assessment tool for quantitative studies, with
relevant considerations to suit the purposes of this review. The following categories were removed
because they were captured by the RoB criteria: randomisation, differences between groups prior
to the intervention, blinding, attrition, intervention integrity, and whether analysis were performed
by intervention allocation status rather than the actual intervention received. Also, given that the
RCT study design was an inclusion criterion, the study designs category was deemed redundant.
Additional categories were added, pertaining to the analysis and report of the results.
Between-study bias
The risk of publication bias was evaluated to determine whether studies reporting statistically signifi-
cant results were more likely to be published, potentially overestimating the real effect size
(Rothstein, Sutton, & Borenstein, 2006). In order to assess whether this type of bias was likely here,
a funnel plot for symmetry was constructed, displaying the effects size of the published studies
against variance, with asymmetry suggesting the possibility of publication bias. However, funnel
plots can be misleading and inaccurate, especially with few studies or if studies are heterogeneous
(Walker, Hernandez, & Kattan, 2008). Because of the subjective nature of interpreting funnel plots the
following objective tests were also used to support conclusions: the trim and fill method (Duval &
Tweedie, 2000), a classic fail safe analysis, computing the number of studies needed to produce a
null result (Rosenthal, 1979), Egger’s test to measure funnel plot asymmetry (Egger, Smith, Schneider,
& Minder, 1997; Sterne et al., 2011) and a comparison of the results between random-effects and
fixed-effects models (Sterne et al., 2011).
Quality of intervention reporting
The intervention descriptions of all included studies were assessed using the Template for Interven-
tion Description and Replication (TIDieR) checklist and guide (Hoffmann et al., 2014). TIDieR is
intended as a tool for study authors and systematic reviewers to describe interventions accurately
and consistently, with enough detail to allow replication. Two reviewers coded each intervention
description against the checklist as being adequately reported, inadequately reported, not reported,
or not applicable to the intervention. To provide a simple assessment of quality for each study, a value
of 1 was assigned where the item was adequately described or not applicable, and a value of 0 where
it was inadequately described or not reported (excluding Modifications and Tailoring items as ‘Not
reported’ does not equate to a negative value, interventions that were not tailored or with no modi-
fications received a score of 1).
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Data analysis and synthesis
STATA’s (Version 12 for Windows) meta-eff (Kontopantelis & Reeves, 2009) command was used to
convert fatigue measures into standardised mean differences (SMDs) and standard errors. A DerSo-
monian–Laird (DerSimonian & Laird, 1986) random effects meta-analysis with 95% confidence inter-
vals using STATA’s metan (Harris et al., 2008) command was performed. A random effects model
output was selected as it is more conservative than a fixed effects model and should be used
when analysing real-world data (Field, 2003; Hunter & Schmidt, 2000). Forest plots were provided.
Fatigue was recoded where necessary so low scores indicate greater fatigue. Where data were
reported on multiple time points, effect sizes were computed for each time point. Across the
studies, the earliest time point was favoured at follow-up.
The chi-squared statistic (Q) was used to test for the presence of heterogeneity across studies. The
degree of statistical heterogeneity was estimated using the I² index, which describes the percentage
of variation due to heterogeneity as opposed to by chance (Higgins & Thompson, 2002). Cochrane
guidance provides cut-offs for interpretation of the magnitude of heterogeneity (Higgins et al., 2011).
A narrative synthesis was conducted following the guidance of Popay et al. (2006) to provide a
textual summary of the findings across all the included studies. The GRADE approach (Schünemann,
Brożek, & Oxman, 2013), a system for grading the quality of the evidence and providing a confidence
judgement on how close the estimated effect is to the true effect, was also applied to the findings. In
order to provide this judgement, the approach draws together information from the various quality
assessments and analyses, such as how well the RoB criteria have been met, whether confounders
have been accounted for, heterogeneity across the studies, the estimated effect’s confidence inter-
vals, and symmetry of the funnel plot.
Sensitivity and subgroup analyses
Sensitivity analysis were performed in order to detect whether the overall effect is affected by the
inclusion of studies with imputed data and the quality of the evidence, specifically the RoB of
each study for the allocation concealment category. This index quality criterion was selected
because Pildal et al. (2007) showed that effect size estimates were inflated in studies with inappropri-
ate allocation concealment. Additionally, the influence of each individual study on the overall meta-
analysis estimate was also examined, using STATA’s metainf command (Tobias, 1999).
Subgroup analyses were also conducted to assess if effect sizes vary according to the following
characteristics (see online Appendix B for a coding manual), selected a priori: (1) country (Western
vs. non-Western), (2) whether participants were fatigued at baseline, (3) fatigue as a primary or sec-
ondary outcome, (4) RRT modality (pre-dialysis care, haemodialysis, peritoneal dialysis, kidney trans-
plantation), (5) intervention provided to control group, (6) level of training of intervention facilitator,
(7) tailoring of the intervention, and (8) intervention components, more specifically: exercise, cogni-
tive-behavioural therapy (CBT) techniques, and relaxation/stress management. Given the limited
number of studies included in this review, formal meta-regression analyses could not be conducted.
Sensitivity and subgroup analyses were conducted on the most complete dataset, using first time-
point data of each study.
Results
Results of the search
The electronic and manual searches resulted in 5057 unique citations. Two review authors (FP and
JLH) screened the titles and abstracts and identified 92 reports as potentially relevant, which were
retrieved for further assessment. After full-text screening, 16 citations were deemed as eligible
according to the inclusion and exclusion criteria (see Figure 1 for the PRISMA flow-chart diagram
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and online Appendix C for the inclusion/exclusion criteria screening table). The included studies
are displayed in Figure 2, from here onwards studies will be referred to by using their reference
number displayed in Figure 2. Citations of the included studies can be found in online Appendix
D. A summary of the study characteristics and demographics are presented in Figure 2. Out of the
16 trials, 14 randomised participants at the individual level, 2 were cluster trials, where dialysis
shifts were randomised rather than participants (7, 12). Six potentially eligible ongoing/not yet pub-
lished trials were identified and these will be considered in future updates of this review (online
Appendix E).
Figure 1. PRISMA flow-chart diagram. This figure shows the flow of the citations through the selection process. Titles and abstracts
of 5057 records were screened. Out of these, 92 full-text articles were assessed for eligibility. Sixteen were deemed as eligible and
14 could be included in the meta-analysis. The most common reasons for exclusion after full-text appraisal were: (1) not measuring
fatigue/vitality as an outcome, (2) failing to report discernible fatigue/vitality findings, and (3) not a randomised or quasirando-
mised controlled study design.
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Figure 2. Graphical representation of the characteristics of the included studies. This figure summarises the main descriptive characteristics of the included studies.1,2 estimated from frequencies; 3not
reported, 4unclear; CG: control group; IG: intervention group; M: male; F: female; QoL: quality of life; indf2f: individual face-to-face; groupf2f: group face-to-face; TAU: treatment as usual; WL: waiting-list
control; Prim: primary outcome; Sec: secondary outcome; VAS: visual analogue scale; SF36: vitality subscale of the SF-36; FSS: fatigue severity scale; PFS: Piper fatigue scale; KTQ25: fatigue subscale of








Characteristics of the included studies
Sixteen trials were included with a total of 1536 randomised participants. Trial sample sizes ranged from
15 to 440 participants. The trials were conducted in 9 different countries: UK (2, 8, 12), USA (13, 15), Aus-
tralia (3), Hong Kong (6, 16), Singapore (4), Taiwan (5, 14), China (9), Iran (1, 7, 11), and Egypt (10).
With regards to demographic characteristics of the samples, there was a fairly equal distribution of
males (51.5%) and females across the studies. Samples of all the included studies consisted of adults,
with a weighted mean age of 60.5. For the studies including dialysis patients, the mean weighted
length on dialysis was 3.78 years. Studies did not specify what proportion of participants were in
receipt of anaemia treatments. A total of 86 participants reported long-term term use of hypnotics
in three studies (4, 5, 14).
Fatigue was a primary outcome in two studies (4, 10), but only the intervention in study 10 was
designed specifically for fatigue. In the rest of the studies, fatigue was a secondary outcome, generally
as part of a broader quality of life assessment (2–3, 6–9, 11–16). Eleven studies used the vitality sub-
scale of the SF-36 as a measure of fatigue, with only three studies relying on a validated fatigue-
specific instrument (4, 5, 10). Six studies (6, 8, 9, 10, 11, 16) assessed outcomes on multiple occasions
after the intervention, while the remaining studies used a single assessment. Ten studies assessed
outcomes shortly after the intervention (less than 6 weeks; 1, 4, 5, 6, 8, 9, 10, 11, 12, 14), while 11
assessed outcomes at longer intervals following the intervention (more than 6 weeks; 2, 3, 6, 7, 8,
9, 10, 11, 13, 15, 16). Out of the 16 studies, only 6 found a significant improvement in fatigue following
the delivered intervention (1, 3–5, 9, 10), 5 of these were carried out among dialysis patients, and only
one was aimed at patients in pre-dialysis care. Two trials could not be included in the meta-analysis
because of the non-normal distribution of their data (4, 7).
Meta-analysis
According to the most complete dataset, relying on the first time-point data of each trial, there was a
small to medium significant effect of social-psychological interventions on fatigue across the 14 RCTs
(N = 1232; SMD = 0.37, p = .001; 95% confidence interval [CI] 0.15 to 0.59, I² = 69.1%, p < .001; See
Figure 3). Social-psychological interventions were associated with a significant improvement in
fatigue. The findings were comparable when examining short-term follow-up data (up to 6 weeks)
and long-term follow-up (more than 6 weeks) (online Appendix F). Heterogeneity was greatest for
follow-up data. Follow-up time points ranged from 2 weeks to 6 months.
Sensitivity analyses
Impact of imputed data and influence of individual studies
Sensitivity analyses were conducted to repeat the primary meta-analytic computations where arbi-
trary decisions were made due to missing information or lack of clarity in the reports. Due to
missing values, data were imputed for two studies (8, 15). More specifically, in study 8, baseline
standard deviations were used at follow-up, while in study 15, vitality values were estimated from
a bar chart. Sensitivity analyses were conducted on the most complete dataset of first time points
excluding these two studies, to assess the impact of imputed data on the meta-analytic findings.
This resulted in a smaller SMD of 0.28 and reduced heterogeneity (p = .004; 95% CI 0.09 to 0.47,
I² = 58.9%, p = .005; see online Appendix G). Online Appendix H shows graphically the influence of
omitting one study in each turn on the overall meta-analysis estimate, with mainly little effect on
the overall meta-analysis estimate and 95% CI.
Quality of the included studies
Studies were rated for quality across the following domains: focus of research question, sample repre-
sentativeness, sampling method, response rate, power calculation, acknowledgement of confounders,
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validity and reliability of the instruments used, appropriateness of the statistical analyses, report of sig-
nificance levels and confidence intervals, and adjustment of the p-value for multiple analyses. Almost all
studies addressed clearly focused questions, provided clear inclusion/exclusion criteria, relied on recog-
nised self-report instruments, and assessed and reported statistical significance. Power calculations
were reported in 10 studies, and 9 studies reported a response rate of 70% or over. Poor methodologi-
cal quality was evident in relation to sample representativeness. Largely studies relied on single-centre
opportunistic recruitment with little attention devoted to confounders and p-value adjustment for mul-
tiple analyses. Confidence intervals were mostly not reported. Please see online Appendix I for the full-
quality assessment of each study. Inter-rater agreement for the quality assessment was generally sub-
stantial, ranging from κ = 0.242 to κ = 1.00. Agreement was lower with regards to the representativeness
of the sample (κ = 0.242) and appropriateness of the statistical methods (κ = 0.360).
With regards to the intervention reporting, the average TiDiER rating across the studies was of 7.5,
suggesting that an adequately described judgement was only granted for around half of the TiDiER
categories (see online Appendix J for a further breakdown for each category). The categories most
often well reported were: Brief Name, Rationale, and Tailoring. Although generally rationales were
provided in the reports, predominantly the interventions were not theory-led, with only a minority
of studies providing adequate detail on any theoretical underpinnings (2, 8, 12, 16). Consistently,
reporting was poor of the Materials and Fidelity categories (planned and actual). Inter-rater agree-
ment for the TiDiER assessment ranged from κ = 0.259 to κ = 0.862.
RoB of the included studies
Due to inadequate reporting across the included studies, it was often not possible to determine
whether a quality or RoB criterion was met. As can be seen from Figure 4 and online Appendix K,
the studies were predominantly of poor quality with a strong prevalence of unclear or high RoB
Figure 3. Forest plot of the effect of social-psychological interventions on fatigue using first time-point data. This diagram is a
graphical representation of the meta-analytic findings, showing the earliest time-point effect sizes and errors of each included
study. There was a significant effect of social-psychological interventions on fatigue, in favour of the intervention.
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judgements, particularly for the categories of incomplete outcome data, selective reporting, blinding,
and other biases, such as poor description of the control condition and likelihood of contamination
between the trial arms. Inter-rater agreement for the RoB assessment was high, ranging from κ =
0.462 (for the category Blinding of Personnel) to κ = 0.830 (for the category Selective Reporting).
Figure 4. RoB summary: review authors’ judgements about each RoB item for each included study. This diagram is a graphical
summary of the judgements for each RoB category each included study received.
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Impact of RoB: allocation concealment
Of those studies meta-analysed, seven studies were rated as low RoB for allocation concealment. To
assess the impact of high or unclear RoB for allocation concealment, the estimated SMD of studies
with high or unclear RoB were compared against those with low RoB for allocation concealment
(see online Appendix L, Figure L.1). This analysis revealed an increased effect of social-psychological
interventions with adequate allocation concealment on fatigue (SMD = 0.43, p = .014; 95% CI 0.09 to
0.77, I² = 74.9%, p = .001). This analysis was rerun, excluding study 15, due to its outlying nature. Once
removed the effect size of social-psychological interventions was reduced to SMD = 0.25 (p = .031;
95% CI 0.02 to 0.48; I² = 44.7%, p = .108; N = 6; see online Appendix L, Figure L.2).
Interventions
Great variability was evident in relation to intervention content and structure. Frequency and dur-
ation of treatment sessions varied considerably among the trials, with a minimum number of 2 ses-
sions (2) and up to 96 sessions (15), with a median of 6 sessions. The majority of interventions were
delivered face-to-face, individually and/or in a group format. Some interventions provided an initial
face-to-face assessment, and subsequently over the phone sessions (3, 6, 9, 16). Across the interven-
tions, most sessions lasted between 30 and 60 minutes (4–6, 8, 10, 12–15). All interventions included
some form of education. The only intervention designed specifically to target fatigue was an edu-
cational intervention (10). Five interventions were CBT-based, two targeting sleep quality (4, 5),
two were aimed at improving adherence to fluid restrictions (8, 12), and one targeting physical func-
tioning (15). The latter also included a physical component, consisting of resistance training (15). Four
interventions revolved around shared-care and the role of practical support from nurses to improve
quality of life (1, 6, 11, 16). In study 2, peer-led support to facilitate access to community support was
offered in order to improve self-management and quality of life. The intervention in study 3 was a
nutrition intervention, revolving around self-management of diet restrictions, in order to improve
nutritional status. Study 7’s intervention was a pharmaceutical care programme aimed at improving
quality of life. The intervention in study 13 was an educational and behavioural intervention, to
increase active participation in daily activities, aimed at improving functional status. Lastly, one inter-
vention was a nurse-led breathing relaxation programme targeting depression (14).
When studies were coded according to BCTs, the following intervention categories were preva-
lent. The majority of interventions involved goal-setting and/or problem-solving (1–3, 6–9, 11–13,
15, 16). Another prevalent category of BCTs used in the interventions was social support. Techniques
from the category of Repetition and Substitution and advice on how to avoid cues for the unwanted
behaviour were provided within CBT-based interventions (4, 5, 8, 12). Stress-management and relax-
ation techniques were used in a minority of interventions (4, 5, 8, 10, 12, 14, 15). Graded tasks were
explicitly only used by one study, to facilitate an increase in self-efficacy around physical activity (13)
and only one study included the use of cues to facilitate performance of physical activity in patients
(13). A minority of interventions also included exercise/physical activity components, alongside
social-psychological strategies (10, 13, 15). For a full summary of the techniques used in each inter-
vention see online Appendix M.
In relation to the comparison group, most studies compared the intervention to a treatment as
usual (1, 3, 7, 10, 13, 16) or waiting-list control (2, 8, 12, 14), with only six studies using an active or
enhanced comparison group (4–6, 9, 11, 15).
Exploratory subgroup (moderator) analyses
Exploratory subgroup analyses were conducted to identify potential moderators of the pooled effect
size of social-psychological interventions on fatigue. The variables used in these analyses were
selected a priori. There was an insufficient number of studies in subcategories of exercise (N = 3),
12 F. PICARIELLO ET AL.
fatigue as a primary outcome (N = 1), non-tailored interventions (N = 2), and interventions targeted at
kidney transplant recipients (N = 3) or patients in pre-dialysis care (N = 2); therefore, the influence of
these factors on the effectiveness of social-psychological interventions on fatigue could not be deter-
mined. The pooled effect size did not seem to vary by country where the study was conducted (online
Appendix N).
Even though pooled effect sizes were similar between studies with fatigued samples versus those
that were deemed non-fatigued (SMD = 0.37 vs. SMD = 0.43, respectively); the pooled effect size
became non-significant for the latter category (online Appendix N). Furthermore, a more conservative
cut-off for vitality (cut-off ≤ 45) resulted in a more pronounced difference in favour of fatigued
samples (online Appendix N).
Similarly, effect sizes were comparable between passive and active/enhanced comparison groups
(SMD = 0.36 vs. SMD = 0.40, respectively). However, the pooled effect size of interventions compared
to an active comparison group became non-significant (online Appendix N).
Surprisingly, when examining the influence of the level of training of the intervention facilitator,
the effect size was smaller for studies with intervention facilitators who received extensive training
and had experience in delivering the intervention (SMD = 0.16, p = .027; 95% CI 0.02 to 0.30, I² =
0%, p = .677) compared to facilitators who received lower levels of training (SMD = 0.56, p = .013;
95% CI 0.12 to 1.00, I² = 81.9%, p < .0001).
When comparing CBT-based interventions with interventions not relying on CBT techniques,
the estimated effect size of CBT-based interventions was larger, but albeit non-significant (SMD =
0.67, p = .086; 95% CI −0.10 to 1.44, I² = 80.3%, p = .002) compared to the other interventions
(SMD = 0.31, p = .005; 95% CI 0.09 to 0.54, I² = 65.6%%, p = .002) (online Appendix N).
The greatest variation in effect emerged between studies including stress-management/relaxation
techniques and those without such techniques. The SMD was greater among interventions including
stress-management/relaxation techniques (SMD = 0.69, p = .007; 95% CI 0.19 to 1.19, I² = 76.7%,
p = .001) compared to interventions without these techniques (SMD = 0.19, p = .032; 95% CI 0.02 to
0.36, I² = 33.2%, p = .163) (online Appendix N).
RoB across studies
The somewhat asymmetrical funnel plot, due to the absence of studies in the lower left corner
(Figure 5), and significant Egger’s statistical test (bias = 2.51; 95% CI 0.15 to 4.88; p = .039) across
all the included studies indicate that the review may be subject to publication bias. When the
risk of publication bias analysis was recomputed excluding studies with imputed data (8, 15),
small study publication bias disappeared, demonstrated by a more symmetrical funnel plot
(online Appendix O) and a non-significant Egger’s statistical test (bias = 1.75; 95% CI −1.21 to
4.70; p = .216).
According to the trim and fill method, an additional four imputed studies would reduce
the pooled effect size to 0.150 (95% CI −0.11 to 0.41), yielding a non-significant effect of social-
psychological interventions on fatigue (p = .259; see online Appendix P). However, this finding
should be interpreted with caution as this method is unreliable in the presence of substantial
between-study heterogeneity (Peters, Sutton, Jones, Abrams, & Rushton, 2007; Terrin, Schmid,
Lau, & Olkin, 2003), as has been observed here. To further assess small study bias, a fixed effects
model was computed and the values were compared to a random effects model output. The
two models were comparable (random-effects: SMD = 0.37, p = .001; 95% CI 0.15 to 0.59, I² =
69.1%, p < .001 vs. fixed-effects: SMD = 0.26, p < .0001; 95% CI 0.15 to 0.37), suggesting only
small bias, without considerable influence on the estimated efficacy of interventions on fatigue.
Finally, a classic fail safe analysis was computed, suggesting that in order to produce a null-
effect of social-psychological interventions on fatigue an additional 129 null-effect studies would
be needed (overall Z score = 19.66).
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GRADE appraisal of the findings
Using the GRADE methodology of appraisal of the quality of the evidence (Schünemann et al., 2013),
the true effect identified by the meta-analysis here is likely to be substantially different from the true
effect of social-psychological interventions on fatigue. This is because of the low methodological
quality, high RoB across many of the categories, indirectness and imprecision of the data, and possi-
bility of publication bias. Please see online Appendix Q for further information on the rating for each
GRADE category.
Discussion
Summary of the findings
The aim of this review was to identify currently available social-psychological interventions for the
management of fatigue in ESKD and to evaluate their efficacy. Sixteen social-psychological interven-
tions were identified, in which the effect on fatigue was tested in an RCT. Although the results of 10
trials failed to find a significant improvement in fatigue following the delivery of a social-psychologi-
cal intervention, the quantitative synthesis demonstrated significant small to moderate improve-
ments in fatigue following social-psychological interventions, across follow up time-points (N = 14;
SMD = 0.37, p = .001; 95% CI 0.15–0.59, I² = 69.1%, p < .001). Except for one trial, none of the interven-
tions were designed specifically to treat fatigue, and findings in relation to energy levels as an
outcome were mostly extrapolated from the SF-36 vitality subscale. The majority of interventions
were aimed at improving quality of life. The CBT-based interventions were either targeting sleep
quality, or adherence to fluid restrictions, or physical functioning. There was some evidence to
suggest greater effectiveness of interventions including stress-management and relaxation tech-
niques for the reduction of fatigue compared to interventions without such techniques and tested
among fatigued patients. The standardised pooled effect size became non-significant for trials
with non-fatigued samples and when interventions were compared to active/enhanced comparison
groups. There was no apparent benefit of CBT-based interventions versus interventions without CBT
techniques.
Figure 5. Funnel plot to assess publication bias. A scatterplot of treatment effect against a measure of study precision, to visually
inspect the studies for publication bias and systematic heterogeneity.
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Overall the identified studies were very different in terms of patient characteristics and interven-
tion content and structure. In general, the quality of the studies appeared low, with many studies
failing to control for confounders, relying on poor statistical methods, and lacking confidence
intervals.
With regards to RoB, there was a strong prevalence of unclear or high RoB judgements especially
evident for the categories of allocation concealment and incomplete outcome data. Many studies
also provided poor descriptions of the comparison group. It is likely, as suggested by Pildal et al.
(2007), that inclusion of studies with high or unclear RoB for allocation concealment may overinflate
the SMD, as has been observed here. Additionally, there was indication for some publication bias.
However, given that fatigue was mainly not the primary outcome, this may be attenuated and just
a reflection of the gap in the literature.
Given the numerous methodological limitations, possibility of publication bias, and high hetero-
geneity from study to study, as it reached and even surpassed 50% (Higgins & Thompson, 2002), the
findings should be interpreted with caution. High heterogeneity was particularly evident in the ana-
lyses of longer term follow-ups, this may stem from considerable variation in lengths of follow-up,
ranging from 2 weeks to 6 months, alongside sample size differences, and differences in RRT and
interventions, with the number of sessions ranging from 2 to 96. Additionally, poor methodological
quality may result in an underestimated effect size of social-psychological interventions, as has been
observed in another systematic review, where trials that relied on appropriate statistical methods,
including use of intention-to-treat, reported a significantly greater effect size compared to exercise
interventions (Kangas et al., 2008). Overall, according to the GRADE approach, the true effect of
social-psychological interventions on renal fatigue is likely to be substantially different from the
effect estimated here.
Previous research
There is increasing recognition regarding the importance of psychological factors in the perpetuation
and maintenance of fatigue symptoms in chronic conditions (Donovan, Small, Andrykowski, Munster,
& Jacobsen, 2007; Irving, Matcham, Ali, & Chalder, 2015; van Kessel & Moss-Morris, 2006). A greater
appreciation for the role of these factors in fatigue has translated into successful psychological inter-
ventions, leading to clinically significant improvements in fatigue symptoms and fatigue-related func-
tional impairment in cancer and Multiple Sclerosis (MS) (Gielissen, Verhagen, Witjes, & Bleijenberg,
2006; van Kessel et al., 2008). A number of systematic reviews are available across chronic conditions
documenting the effectiveness of a range of social-psychological interventions for fatigue, with small
to moderate effect sizes according to Cohen’s classification (Cramp et al., 2013; Jacobsen et al., 2007;
Kangas et al., 2008; Neill et al., 2006; van den Akker et al., 2016).
Although, in one study, both CBT designed specifically to treat social-psychological factors main-
taining fatigue and relaxation training (RT) showed significant improvements in MS fatigue, the
reduction in fatigue was greater in the CBT group over time compared to the RT group, as well as
CBT yielding improvements in depression and anxiety (van Kessel et al., 2008). This was not observed
here, the estimated effect size of CBT-based interventions was larger, but not significant compared to
the other interventions without CBT techniques. A possible explanation for this finding is that as inter-
ventions were not designed specifically to improve fatigue, fatigue-specific beliefs, and behaviours
were not addressed in treatment. In fact, studies that have evaluated the mechanisms of change fol-
lowing CBT corroborate the mediating role fatigue beliefs play in treatment effectiveness (Chalder,
Goldsmith, White, Sharpe, & Pickles, 2015; Knoop, Van Kessel, & Moss-Morris, 2012; Wiborg, Knoop,
Prins, & Bleijenberg, 2011). In fact, according to Knoop et al. (2012)’s analyses, the reduction in
fatigue following CBT was unrelated to improvements in depression, emphasising the importance
of specific fatigue-related beliefs being targeted within the intervention rather than general negative
self-evaluations that are characteristic of depression. Any secondary benefits of non-fatigue-specific
CBT interventions on energy levels may be the result of addressing more general beliefs about the
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illness and other symptoms during treatment (Skerrett & Moss-Morris, 2006; van der Werf, Evers,
Jongen, & Bleijenberg, 2003) or the benefits of improved mood on fatigue (Knoop et al., 2012;
Stepanski et al., 2009).
Similar to the findings here, the primary aim of most social-psychological interventions, among
cancer and rheumatoid arthritis patients, is rarely fatigue reduction and there is often no apparent
consideration of fatigue mechanisms (Cramp et al., 2013; Kangas et al., 2008). As a consequence,
levels of fatigue are consistently not specified as an inclusion criterion, possibly leading to samples
without clinically significant severe fatigue and therefore resulting in a ceiling effect (Cramp et al.,
2013; Kangas et al., 2008). In fact, the fatigue effect size estimated here became non-significant in
samples that were deemed non-fatigued compared to fatigued ones. The importance of fatigue
being the target of treatment within social-psychological treatment models has been accentuated
by a systematic review of non-pharmacological fatigue interventions in cancer, where moderation
analyses revealed the superiority of social-psychological interventions aimed at fatigue (including
a fatigue aim or hypothesis) compared to exercise interventions aimed at fatigue; whereas the oppo-
site was true across non-fatigue-specific interventions (Kangas et al., 2008). This indicates that the
effect size of social-psychological interventions found here may be underestimated due to the lack
of fatigue-specific focus among the included studies.
Potential biases in the review process
Our study identification and data extraction procedures adhered to Cochrane’s robust
methodological procedures and involved more than one researcher at each stage, thus allowing
greater confidence in the validity and reliability of our review findings. As per Cochrane guidelines,
the effect of methodologically strong and weak studies was explored throughout the meta-analytic
work.
The main weakness of the current review was the intentionally broad inclusion criteria that
resulted in high heterogeneity between the included studies. The definition of a social-psychological
intervention was wide-ranging and renal patients undergoing different types of RRT or in pre-dialysis
care were included. This was done to ensure the inclusion of all social-psychological interventions
that may have potential to reduce renal fatigue. Poor Kappa agreements were evident for some
more subjective and less quantifiable categories of the TIDieR and EPHPP assessments. Additionally,
because the number of studies included in this review was relatively small, it was statistically inap-
propriate to perform formal moderation analyses.
Implications for research and practice
Social-psychological interventions may help to reduce fatigue in ESKD; however, there is currently
a gap in theory-driven social-psychological interventions aimed at fatigue and evaluated in
methodologically rigorous trials. There is extensive evidence in support of CBT for the treatment
of fatigue, including techniques like goal-setting, graded tasks, and pacing aimed at fatigue
(Kangas et al., 2008; van den Akker et al., 2016; White et al., 2011). However, there is need for a
clear framework that elaborates on what fatigue beliefs and behaviours should be the target of treat-
ment. Future interventions need to focus specifically on fatigue and be conducted with fatigued
samples. This review highlighted an over-reliance on the vitality subscale as a marker of fatigue,
although relatively consistent across studies this simplifies pooling of data, the consistent use of a
fatigue-specific instrument validated in ESKD would increase the trustworthiness of the findings.
Additionally, medications used for the management of anaemia need to be accounted for when
looking at fatigue as an outcome. Further to this, it is essential that trials are reported in line with
the CONSORT statement.
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Conclusion
In conclusion, this meta-analytic review supports the efficacy of social-psychological interventions for
the management of fatigue in ESKD. However; there was high variability across the studies, poor
methodological quality, and possibility of publication bias which undermine the findings reported
here. Given the successful application of social-psychological interventions for the management of
fatigue in other chronic conditions and the additional burden fatigue poses on renal patients; devel-
opment and evaluation of a fatigue-specific social-psychological intervention is warranted in this
patient population. It is important that any fatigue intervention is tested in participants who are fati-
gued, to ensure that the potential efficacy is not merely masked by a ceiling effect.
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